 |
|
Stealth particles to target tumors
September 01, 2005Stealth nano particles may some day target tumor cells and deliver medication to specific body locations, according to Penn State chemical engineers.
"Mainly we have focused on chemotherapy drugs," says Dr. Michael Pishko, professor of chemical engineering and materials science and engineering. "But others are considering using this delivery system to deliver genes in gene therapy."
The researchers first produce nano-sized powders of the drug they wish to deliver and encapsulate them in a polymer nanoshell. The drug used for this project was paclitaxel - an anti breast cancer drug - and dexamethasone - a steroid frequently used to treat eye inflammation. This shell allows the drug to travel in stealth mode through the bloodstream.
"A layer-by-layer self-assembly technique was used to encapsulate core charged drug nanoparticles in a polymeric nanoshell," the researchers told attendees today (Aug. 31) at the 230th American Chemical Society Meeting, Washington, D.C.
Normally, drugs, especially the toxic drugs used for chemotherapy, trigger the human immune system into action, but, with the polymer shell for protection, these drugs can circulate longer without being removed.
"If the drugs do not trigger an immune response, then lower levels of drug can be used than currently are necessary in chemotherapy," says Pishko.
The researchers, who include Pishko, Alisar Zahr and Cheryl A. Rumbarger, graduate students in chemical engineering, tested their nanoshell in cell culture and found that it had less phagocytosis - removal of the drug - during a 24-hour period than the unencapsulated drug.
Combined with longer retention in the body, the researchers engineered the nanoparticle shells to target specific cells by attaching a functionalized polymer to the shell. They designed this tentacle-like projection to target a receptor on a tumor cell, or a specific location in the eye, for example. Once the drug arrives via the blood to the tumor or eye, it attaches and slowly releases its contents.
This type of drug delivery system works especially well in such highly vascularized areas such as tumors and the eye, because the drug can travel right up to the target area. Delivery to areas in the brain would not be feasible because of the blood brain barrier that prevents foreign substances from moving from the blood into the cells of the brain.
"For targeting, we could exploit the fact that cancer tumors have a lot more folic acid receptors and target those," says Pishko. "We could also use specific monoclonal antibodies to target specific tumors."
The researchers also considered delivery of drugs to specific type cells, like those in the eye. This type of stealth targeting drug delivery system could also deliver genes or gene fragments in gene therapy.
Penn State
"A layer-by-layer self-assembly technique was used to encapsulate core charged drug nanoparticles in a polymeric nanoshell," the researchers told attendees today (Aug. 31) at the 230th American Chemical Society Meeting, Washington, D.C.
Normally, drugs, especially the toxic drugs used for chemotherapy, trigger the human immune system into action, but, with the polymer shell for protection, these drugs can circulate longer without being removed.
"If the drugs do not trigger an immune response, then lower levels of drug can be used than currently are necessary in chemotherapy," says Pishko.
The researchers, who include Pishko, Alisar Zahr and Cheryl A. Rumbarger, graduate students in chemical engineering, tested their nanoshell in cell culture and found that it had less phagocytosis - removal of the drug - during a 24-hour period than the unencapsulated drug.
Combined with longer retention in the body, the researchers engineered the nanoparticle shells to target specific cells by attaching a functionalized polymer to the shell. They designed this tentacle-like projection to target a receptor on a tumor cell, or a specific location in the eye, for example. Once the drug arrives via the blood to the tumor or eye, it attaches and slowly releases its contents.
This type of drug delivery system works especially well in such highly vascularized areas such as tumors and the eye, because the drug can travel right up to the target area. Delivery to areas in the brain would not be feasible because of the blood brain barrier that prevents foreign substances from moving from the blood into the cells of the brain.
"For targeting, we could exploit the fact that cancer tumors have a lot more folic acid receptors and target those," says Pishko. "We could also use specific monoclonal antibodies to target specific tumors."
The researchers also considered delivery of drugs to specific type cells, like those in the eye. This type of stealth targeting drug delivery system could also deliver genes or gene fragments in gene therapy.
Penn State
Tumors Current Events and Tumors News RSSGenetic breakdown in Fanconi anemia may have link to HPV-associated cancer
A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene.
Researchers Discover New Enzyme in Cancer Growth
While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body.
EEGs show brain differences between poor and rich kids
University of California, Berkeley, researchers have shown for the first time that the brains of low-income children function differently from the brains of high-income kids.
Dancing atoms now understood
In developing a model to explain the motion of atoms in a magnetic field, scientists have overcome a decades-old obstacle to understanding a key component of magnetic resonance.
New statistical model could help reduce breast-lesion biopsies
A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA).
Combining targeted therapy drugs may treat previously resistant tumors
A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches.
Prostate cancer spurs new nerves
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Breast cancer treatment offers better outcome to women with implants
Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Study unmasks how ovarian tumors evade immune system
Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked
Studies show novel device may enhance chemotherapy treatment in brain tumors
NovoCure Ltd. presented results yesterday evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients.
More Tumors Current Events and Tumors News Articles
 | Living with a Brain Tumor: Dr. Peter Black's Guide to Taking Control of Your Treatment by Peter Black Each year, 100,000 people in the United States are diagnosed with a brain tumor. With his new book, Dr. Peter Black fills a gap in the lay readership, providing an accessible medical resource for adult patients and their families. Dr. Black, who has operated on more than 3,000 patients with brain tumors, is uniquely qualified to discuss both clinical treatment of and research into brain tumors.... |
 | Enzinger and Weiss's Soft Tissue Tumors with CD-ROM by Sharon W. Weiss, John R. Goldblum Here's your ideal reference on the diagnosis of tumors of the skeletal muscles, connective tissue, fat, and related structures. No other textbook matches its scope and depth of coverage in this complex and challenging area of surgical pathology, and no other text contains as much practical information on differential diagnosis. Throughout, microscopic findings are correlated with the latest... |
 | Imaging of Soft Tissue Tumors by Mark J Kransdorf, Mark D Murphey Based on a vast number of cases seen at the Armed Forces Institute of Pathology and the Mayo Clinic, this volume is a comprehensive reference on the radiologic evaluation of soft tissue tumors. The book covers the entire spectrum of soft tissue pathologies, with over 1,400 images showing common and atypical appearances. The authors discuss the relative utility of all imaging modalities in... |
 | Curveball: When Life Throws You a Brain Tumor by Liz Holzemer Life seemed idyllic for thirty-two-year-old Liz Holzemer. Wife of Major League Baseball pitcher Mark Holzemer, Liz was enjoying a successful career as a journalist when an MRI revealed a baseball-size brain tumor she soon found out was called meningioma. Told with clarity and unwavering humor, this book is an inspirational and informative account of one woman's battle for her life. It shows... |
 | Damn The Statistics, I Have a Life to Live!: Coping with a Brain Tumor My Personal Story by H. Charles Wolf |
 | Brain Tumors: Leaving the Garden of Eden--A Survival Guide to Diagnosis, Learning the Basics, Getting Organized, and Finding Your Medical Team by Paul M. Zeltzer A guidebook for the 150,000+ people/ year and families affected by brain tumors. This book will help you learn the basics about diagnosis, getting organized and finding your medical team. Included are chapters on all major types of brain tumors & metastases, glossary, medications, using the Internet to search for information, and getting a second opinion. "Brain Tumors:Leaving the Garden of... |
| Non-Tumor Gastrointestinal Diseases (Atlas of Nontumor Pathology) by Amy Noffsinger, Cecilia M. Fenoglio-Preiser, Dipen Maru, Norman Gilinsky | |
 | Tumors of the Spine by Daniel H. Kim, Ung-kyu Chang, Se-Hoon Kim, Mark H. Bilsky Achieve optimal outcomes for your patients with this new multimedia reference. Organized by tumor then by region, this resource details diagnostic and therapeutic options for primary and malignant spinal tumors. Over 25 key procedures--including minimally invasive surgery--are presented in a concise, stepwise fashion, putting the key information you need right at your fingertips! Over 600... |
 | 100 Questions & Answers About Gastrointestinal Stromal Tumor(GIST) by Ronald DeMatteo, Marina Symcox, George D. Demetri Whether you're a newly diagnosed GI Stromal patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor's and patient's views, 100 Questions & Answers About Gastrointestinal Stromal Tumor (GIST) gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much... |
 | Surgery for the Bone and Soft-Tissue Tumors by Michael A Simon, Dempsey S Springfield This volume is a comprehensive guide to the diagnosis and treatment of both benign and malignant tumors of the bone and soft tissues. The first section addresses general issues in diagnosis, staging, surgery, radiation therapy, and chemotherapy and includes a valuable chapter on the psychological aspects of patient management--a subject not covered in standard texts on musculoskeletal tumors.... |
| © 2008 BrightSurf.com |